Real-time enrollment status for this adenovirus infections clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:01 PM UTC
| NCT Number | NCT07387367 |
| Recruiting Status | Recruiting |
| Condition | Adenovirus Infections |
| Phase | PHASE3 |
| Target Enrollment | 180 participants |
| Active Locations | 32 sites in the US |
| Sponsor | SymBio Pharmaceuticals |
| Last Updated on CT.gov | August 10, 2026 (Aug 10, 2026) |
As of October 12, 2026: Clinical trial NCT07387367 is currently recruiting participants. This phase3 study for adenovirus infections is actively seeking new participants at 32 locations across the United States. The study is sponsored by SymBio Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07387367 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 32 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07387367 was last updated Aug 10, 2026 (August 10, 2026). HelloStudys verifies this status automatically.